Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Gene therapy improves age-related cardiac disorder in rats

Feb. 23, 2000

New phenethylsulfones synthesized at Celgene useful for inflammation, etc.

Feb. 23, 2000

JTV-519 may provide cardioprotection by mimicking preconditioning

Feb. 22, 2000

Effective new antianginal agents under study at Lafon

Feb. 22, 2000

NicOx initiates French phase I trial of new oral formulation of NCX-4016

Feb. 22, 2000

NCBE inhibitors in development at Aventis

Feb. 21, 2000

High- vs. low-dose enalapril compared for immunological effects in CHF

Feb. 21, 2000

Adenosine A1 antagonists as alternatives to diuretics in CHF

Feb. 18, 2000

UCSD researchers report fundamental breakthrough in treating, preventing shock

Feb. 18, 2000

Promising new atherosclerosis treatment expected to enter clinical trials later this year

Feb. 18, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...